Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9:193–9.

Article  PubMed  PubMed Central  Google Scholar 

Baskar R, Dai J, Wenlong N, Yeo R, Yeoh KW. Biological response of cancer cells to radiation treatment. Front Mol Biosci. 2014;1:24.

Article  PubMed  PubMed Central  Google Scholar 

Chetty IJ, et al. Technology for Innovation in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015;93:485–92.

Article  PubMed  PubMed Central  Google Scholar 

Feain IJ, Court L, Palta JR, Beddar S, Keall P. Innovations in Radiotherapy Technology. Clin Oncol (R Coll Radiol (G B)). 2017;29:120–8.

Article  CAS  Google Scholar 

Jaffray DA. Image-guided radiotherapy: from current concept to future perspectives. Nat Rev Clin Oncol. 2012;9:688–99.

Article  CAS  PubMed  Google Scholar 

Jiang GL. Particle therapy for cancers: a new weapon in radiation therapy. Front Med. 2012;6:165–72.

Article  PubMed  Google Scholar 

Welsh JS, et al. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Cancer Res Treat. 2002;1:311–6.

Article  PubMed  Google Scholar 

Blomain ES, Moding EJ. Liquid biopsies for Molecular Biology-based Radiotherapy. Int J Mol Sci 22 (2021).

Huang C, et al. The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study. BMC Cancer. 2023;23:505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ree AH, Redalen KR. Personalized radiotherapy: concepts, biomarkers and trial design. Br J Radiol. 2015;88:20150009.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tran PT, et al. Tissue biomarkers for prostate cancer radiation therapy. Curr Mol Med. 2012;12:772–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee DS et al. Association between Posttreatment Serum Platelet-to-Lymphocyte Ratio and distant metastases in patients with Hepatocellular Carcinoma receiving curative Radiation Therapy. Cancers 15 (2023).

Li A, et al. Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases. Future Oncol (London England). 2020;16:2433–44.

Article  CAS  Google Scholar 

An L, Yin WT, Sun DW. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible? BMC Cancer. 2021;21:247.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in Rheumatic diseases. Annals Lab Med. 2019;39:345–57.

Article  CAS  Google Scholar 

Li P, Li H, Ding S, Zhou JNLR. PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma. Am J Translational Res. 2022;14:3017–27.

CAS  Google Scholar 

Lin ZX, et al. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection. World J Gastroenterol. 2015;21:10898–906.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

Article  CAS  PubMed  Google Scholar 

Langsenlehner T, et al. Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy. Urol Oncol. 2015;33:e201209–216.

Article  Google Scholar 

Pinedo HM, Verheul HM, D’Amato RJ, Folkman J. Involvement of platelets in tumour angiogenesis? Lancet (London England). 1998;352:1775–7.

Article  CAS  PubMed  Google Scholar 

Bakewell SJ, et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc Natl Acad Sci USA. 2003;100:14205–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boucharaba A, et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Investig. 2004;114:1714–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabrkhany S, Griffioen AW, Oude Egbrink MG. The role of blood platelets in tumor angiogenesis. Biochim Biophys Acta. 2011;1815:189–96.

CAS  PubMed  Google Scholar 

Leone K, Poggiana C, Zamarchi R. The interplay between circulating Tumor cells and the Immune System: from Immune escape to Cancer Immunotherapy. Diagnostics (Basel Switzerland) 8 (2018).

Abravan A, Salem A, Price G, Faivre-Finn C, van Herk M. Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study. Acta Oncol (Stockholm Sweden). 2022;61:163–71.

Article  CAS  Google Scholar 

Duque-Santana V, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors in locally advanced rectal Cancer. Oncology. 2023;101:349–57.

Article  CAS  PubMed  Google Scholar 

Gao Z, Zhao M, Yang X, Fu J. Assessment of Peripheral platelet to lymphocyte ratio and Prognostic Nutritional Index in the efficacy and prognosis of Radiotherapy for Cervical Cancer. Curr Oncol (Toronto Ont). 2023;30:2834–44.

Article  Google Scholar 

McLaren PJ, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios can predict treatment response to Neoadjuvant Therapy in Esophageal Cancer. J Gastrointest Surgery: Official J Soc Surg Aliment Tract. 2017;21:607–13.

Article  Google Scholar 

Van Berckelaer C, et al. A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer. Breast (Edinburgh Scotland). 2020;53:212–20.

Article  PubMed  Google Scholar 

Zhang J, et al. Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a meta-analysis. Future Oncol (London England). 2020;16:117–27.

Article  CAS  Google Scholar 

Bae BK et al. The significance of systemic inflammation markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 14 (2022).

Fiore M, et al. Preoperative neutrophil-to-lymphocyte ratio and a new inflammatory biomarkers Prognostic Index for primary retroperitoneal sarcomas: Retrospective Monocentric Study. Clin cancer Research: Official J Am Association Cancer Res. 2023;29:614–20.

Article  CAS  Google Scholar 

Huang YM et al. Histopathological and Haemogram Features Correlate with prognosis in rectal Cancer patients receiving Neoadjuvant Chemoradiation without Pathological Complete response. J Clin Med 11 (2022).

Ma JY, Ke LC, Liu Q. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: a meta-analysis. Medicine. 2018;97:e12897.

Article  PubMed  PubMed Central  Google Scholar 

Peng RR, et al. Nomogram based on Lactate dehydrogenase-to-albumin ratio (LAR) and platelet-to-lymphocyte ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma. J Inflamm Res. 2021;14:4019–33.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Q, et al. Initial platelet-to-lymphocyte count as prognostic factor in limited-stage small cell lung cancer. Biomark Med. 2019;13:249–58.

Article  CAS  PubMed  Google Scholar 

Yersal Ö, Odabaşi E, Özdemir Ö, Kemal Y. Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioblastoma. Mol Clin Oncol. 2018;9:453–8.

CAS  PubMed  PubMed Central  Google Scholar